Published in Lancet on January 11, 2003
Bacterial contamination of blood components. Clin Microbiol Rev (2005) 2.63
Two novel real-time reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates. J Clin Microbiol (2004) 0.97
Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period. Blood Transfus (2011) 0.95
Deactivation of human immunodeficiency virus type 1 in medium by copper oxide-containing filters. Antimicrob Agents Chemother (2007) 0.88
Quality indicators for discarding blood in the National Blood Center, Kuala Lumpur. Asian J Transfus Sci (2012) 0.86
Alternative procedures for reducing allogeneic blood transfusion in elective orthopedic surgery. HSS J (2010) 0.85
Patients' positive identification systems. Blood Transfus (2009) 0.85
Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis. Blood Transfus (2014) 0.82
Risk analysis of blood transfusion requirements in emergency and elective spinal surgery. Eur Spine J (2010) 0.81
Bacterial contamination of donor blood at the Tamale Teaching Hospital, Ghana. Afr Health Sci (2009) 0.81
Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations. Int J Angiol (2011) 0.80
Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer. World J Gastroenterol (2014) 0.78
Current status of blood transfusion and antifibrinolytic therapy in orthopedic surgeries. Front Surg (2015) 0.78
Antifibrinolytic agents in traumatic hemorrhage. MedGenMed (2005) 0.78
Changes in HIV and AIDS in the United States: Entering the Third Decade. Curr Infect Dis Rep (2005) 0.77
Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics. Anesth Analg (2011) 0.76
Chapter 4: Red cell transfusion to treat anemia in CKD. Kidney Int Suppl (2011) (2012) 0.75
Modulation of oxidative stability of haemoglobin inside liposome-encapsulated haemoglobin. J Microencapsul (2012) 0.75
Antifibrinolytic agents in traumatic haemorrhage. PLoS Med (2005) 0.75
Frozen blood. Lancet (2003) 0.75
Septic shock during platelet transfusion in a patient with acute myeloid leukaemia. BMJ Case Rep (2013) 0.75
Performance Assessment of Internal Quality Control (IQC) Products in Blood Transfusion Compatibility Testing in China. PLoS One (2015) 0.75
Importance of language. Lancet (2003) 0.75
Blood transfusion, serum ferritin, and iron in hemodialysis patients in Africa. J Blood Transfus (2015) 0.75
Testing for risk and protective trends in genetic analyses of HIV acquisition. Biostatistics (2014) 0.75
Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev (2017) 0.75
Seroprevalence, cost per donation and reduction in blood supply due to positive and indeterminate results for infectious markers in a blood bank in Lima, Peru. Rev Bras Hematol Hemoter (2017) 0.75
Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med (2012) 5.77
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg (2011) 4.84
The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective? Ann Thorac Surg (2010) 3.45
Pay for performance in critical care: an executive summary of the position paper by the Society of Critical Care Medicine. Crit Care Med (2009) 2.78
Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med (2014) 2.63
Patient blood management. Anesthesiology (2012) 2.49
Continuous Noninvasive Hemoglobin Monitoring: A Measured Response to a Critical Review. Anesth Analg (2016) 2.03
Evidence-based practice guidelines for plasma transfusion. Transfusion (2010) 1.98
Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion (2003) 1.73
Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev (2011) 1.72
Blood use in elective surgery: the Austrian benchmark study. Transfusion (2007) 1.64
Red blood cell transfusion in critically ill children: a narrative review. Pediatr Crit Care Med (2011) 1.55
When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia. Anesth Analg (2010) 1.49
Rapid increases in parasitemia following red cell exchange for malaria. J Clin Apher (2011) 1.46
Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. Ann Thorac Surg (2004) 1.43
Multidisciplinary approach to the challenge of hemostasis. Anesth Analg (2009) 1.37
Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management. Oncologist (2011) 1.10
Management of a Jehovah's Witness Patient with Sepsis and Profuse Bleeding After Emergency Coronary Artery Bypass Graft Surgery: Rethinking the Critical Threshold of Oxygen Delivery. A A Case Rep (2015) 1.08
Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. J Clin Apher (2013) 1.00
Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg (2005) 0.97
Current status of pharmacologic therapies in patient blood management. Anesth Analg (2012) 0.95
Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Med Rev (2005) 0.94
Multidisciplinary management of a Jehovah's Witness patient for the removal of a renal cell carcinoma extending into the right atrium. Can J Anaesth (2002) 0.93
Blood management. Arch Pathol Lab Med (2007) 0.92
Thrombotic thrombocytopenic purpura and urinary tract infections: is there a connection? Am J Clin Pathol (2011) 0.92
The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments. Transfusion (2009) 0.91
Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage. Anesthesiology (2006) 0.90
Iron: the new advances in therapy. Best Pract Res Clin Anaesthesiol (2013) 0.89
Choice of hemostatic agent and hospital length of stay in cardiovascular surgery. Semin Cardiothorac Vasc Anesth (2009) 0.87
The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion (2014) 0.87
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer. Cancer Immunol Immunother (2004) 0.87
Blood salvage use in gynecologic oncology. Transfusion (2009) 0.86
Iron deficiency anemia in women across the life span. J Womens Health (Larchmt) (2012) 0.86
Intraoperative blood salvage: a mathematical perspective. Transfusion (2002) 0.85
Bloodless surgery in a Jehovah's Witness patient with a 12.7-kg uterine leiomyosarcoma. J Surg Educ (2007) 0.85
Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy. J Clin Apher (2004) 0.84
Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy. J Clin Apher (2009) 0.84
How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. Blood (2011) 0.84
Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol (2013) 0.84
The chiasm: transfusion practice versus patient blood management. Best Pract Res Clin Anaesthesiol (2013) 0.84
Liberal or Restrictive Transfusion after Cardiac Surgery. N Engl J Med (2015) 0.84
Blood conservation strategies in Jehovah's Witness patients undergoing complex aortic surgery: a report of three cases. J Cardiothorac Vasc Anesth (2003) 0.84
Anaemia: can we define haemoglobin thresholds for impaired oxygen homeostasis and suggest new strategies for treatment? Best Pract Res Clin Anaesthesiol (2013) 0.83
Use of the Hemobag for modified ultrafiltration in a Jehovah's Witness patient undergoing cardiac surgery. J Extra Corpor Technol (2006) 0.83
Transfusion medicine illustrated. Visualizing the hemolytic transfusion reaction. Transfusion (2003) 0.83
Postoperative blood loss and transfusion associated with use of Hextend in cardiac surgery patients at a blood conservation center. Transfusion (2008) 0.82
Introduction. Best Pract Res Clin Anaesthesiol (2013) 0.82
Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature. Transfusion (2010) 0.82
ADAMTS13 activity levels in patients with human immunodeficiency virus-associated thrombotic microangiopathy and profound CD4 deficiency. J Clin Apher (2009) 0.81
The theory and practice of bloodless surgery. Transfus Apher Sci (2002) 0.81
Variability in transfusion practice and effectiveness of strategies to improve it. J Cardiothorac Vasc Anesth (2012) 0.80
Life, death, and the risk of transfusion: a university hospital experience. Transfusion (2006) 0.79
Update on erythropoiesis-stimulating agents. Best Pract Res Clin Anaesthesiol (2013) 0.79
In vitro analysis of cell salvage blood collection with a laparoscopic suction device. J Minim Invasive Gynecol (2013) 0.79
Anemia, bleeding, and blood transfusion in the intensive care unit: causes, risks, costs, and new strategies. Am J Crit Care (2013) 0.78
Hemoglobin-based oxygen carrier (HBOC-201) and escalating doses of recombinant factor VIIa (rFVIIa) as a novel pre-hospital resuscitation fluid in a swine model of severe uncontrolled hemorrhage. Artif Cells Blood Substit Immobil Biotechnol (2010) 0.77
Anemia screening in elective surgery: definition, significance and patients' interests. Anesth Analg (2006) 0.77
Patient blood management and outcome, too early or not? Best Pract Res Clin Anaesthesiol (2013) 0.77
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies. Biol Blood Marrow Transplant (2003) 0.77
How we approach an acquired thrombotic thrombocytopenic purpura patient. Transfusion (2014) 0.76
Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state. Ther Apher Dial (2006) 0.76
Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: Fall 2004 impact survey. Transfusion (2006) 0.76
What Is the PROPPR Transfusion Strategy in Trauma Resuscitation? Anesth Analg (2016) 0.76
More on transfusion and adverse outcome: it's time to change. Anesthesiology (2011) 0.76
A reductionistic approach to aged blood. Anesthesiology (2010) 0.76
In reply. Anesthesiology (2013) 0.76
Posttransfusion Increase of Hematocrit per se Does Not Improve Circulatory Oxygen Delivery due to Increased Blood Viscosity. Anesth Analg (2017) 0.76
Resurrecting the iron age*. Crit Care Med (2012) 0.75
Fatal streptococcal infection despite routine bacterial culture screening. Transfusion (2008) 0.75
Invited commentary. Ann Thorac Surg (2004) 0.75
The long and winding road of acute normovolemic hemodilution. Transfusion (2006) 0.75
Hemoglobin-based blood substitutes and risk of myocardial infarction and death. JAMA (2008) 0.75
Hydroxyethyl starch and risk of bleeding: the missing links. Anesth Analg (2006) 0.75
Blood and starch in cardiac surgery. Chest (2004) 0.75
Does acute normovolemic hemodilution work in cardiac surgery? Anesthesiology (2002) 0.75
Another headache for anemia. Crit Care Med (2007) 0.75
Caveats of bispectral index monitoring in the pediatric population. Chest (2005) 0.75
Are women who are Jehovah's Witnesses at risk of maternal death? Am J Obstet Gynecol (2002) 0.75
Modeling of bacterial contamination. Transfusion (2008) 0.75
The evidence shows that allogeneic transfusion is associated with reduced survival after coronary artery bypass surgery. Anesthesiology (2010) 0.75
National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative Review. Anesth Analg (2016) 0.75
A case of no pain and no gain from blood? Crit Care Med (2009) 0.75
Case 3-2008. The use of acute normovolemic hemodilution during cardiac surgery in a patient with human immunodeficiency virus infection. J Cardiothorac Vasc Anesth (2008) 0.75
The Taxonomy of Calamity: The View From the Operating Room. Int Anesthesiol Clin (2015) 0.75
Pre-transfusion phenotype matching for sickle cell disease patients. Transfusion (2004) 0.75
Power, Knowledge, and Transfusions: The Need to Refocus on Patient Blood Management. Jt Comm J Qual Patient Saf (2017) 0.75
Current concepts in reoperative cardiac surgery. Semin Cardiothorac Vasc Anesth (2009) 0.75
Validation of pH and glucose determination for bacteria detection screening in platelet concentrates stored in the Terumo Teruflex XT612 platelet container. Transfusion (2004) 0.75
Transfusion medicine illustrated. Clumping in an apheresis-collected peripheral blood progenitor cell product. Transfusion (2008) 0.75
The introduction of 7-day platelets: a university hospital experience. J Clin Apher (2007) 0.75
Package insert for rhesus immune globulin. Obstet Gynecol (2004) 0.75
The platelet prophylactic transfusion trigger: when expectations meet reality. Transfusion (2007) 0.75
Transfusion Medicine Illustrated. Monoclonal antibody-stimulated serum sickness. Transfusion (2004) 0.75
Theoretical efficacy of using albumin/plasma versus full plasma replacement in TTP. J Clin Apher (2010) 0.75
Validation of a microbial detection system for use with ACD-A platelets with PAS III platelet additive solution. Transfusion (2011) 0.75
Transfusion medicine illustrated. G-CSF-associated rash in an allogeneic PBPC donor. Transfusion (2003) 0.75
Update on multi-center clinical trials in the United States. Transfus Apher Sci (2007) 0.75
Adjusting surgical bleeding for dilutional effect of Hextend. Transfusion (2008) 0.75
Evolution in alternatives to blood transfusion. Hematol J (2003) 0.75